This company seems to have been delisted
Reason: Liquidation
Last recorded trade on: February 20, 2025
Source: https://globalgenes.org/raredaily/bellerophons-board-agrees-to-liquidate-after-trial-failures-and-layoffs/
Reason: Liquidation
Last recorded trade on: February 20, 2025
Source: https://globalgenes.org/raredaily/bellerophons-board-agrees-to-liquidate-after-trial-failures-and-layoffs/
Bellerophon Therapeutics
BLPH
HK$0.09420
Share price
-36.84%
Change (1 day)
-79.90%
Change (1 year)
Categories
Bellerophon Therapeutics (BLPH) - Total liabilities
Total liabilities on the balance sheet as of September 2023 : HK$9.85 Million
According to Bellerophon Therapeutics 's latest financial reports the company's total liabilities are HK$9.85 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Bellerophon Therapeutics - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | HK$42.19 M | 2.97% |
| 2021-12-31 | HK$40.98 M | -55.91% |
| 2020-12-31 | HK$92.94 M | 25.4% |
| 2019-12-31 | HK$74.11 M | -34.74% |
| 2018-12-31 | HK$0.11 B | -63.11% |
| 2017-12-31 | HK$0.30 B | 239.03% |
| 2016-12-31 | HK$90.8 M | 45.12% |
| 2015-12-31 | HK$62.57 M | -22.83% |
| 2014-12-31 | HK$81.08 M | -46.02% |
| 2013-12-31 | HK$0.15 B | 33.98% |
| 2012-12-31 | HK$0.11 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Baxter BAX | HK$111.85 B | 1,134,454.14% | 🇺🇸 USA |
 Abeona Therapeutics
ABEO | HK$0.45 B | 4,515.29% | 🇺🇸 USA |
 Abbott Laboratories ABT | HK$254.20 B | 2,578,243.95% | 🇺🇸 USA |
 Lantheus Holdings LNTH | HK$6.99 B | 70,841.88% | 🇺🇸 USA |